Press Releases

This needs text.

• U.S. Congressman Michael Capuano to Receive "Lou Gehrig Award" from ALS TDI during Gala Event this November (June 7, 2011)
• Pharma and Biotech CEOs, Academic Scientists, Funders and Patients to Meet on ALS Drug Development this Fall (June 6, 2011)
• ALS TDI Earns Four Star Rating for the Second Consecutive Year (May 13, 2011)
• ALS TDI Recognized for World Class Research by the ALS Association (May 12, 2011)
• Minnesota's Longest ALS Bike Ride to Support Two Charities Serving those Living with Lou Gehrig's Disease (May 9, 2011)
• World Record Holding Pilot to Kick Off Latest World Flight with Stop Over and Lecture in Boston (April 22, 2011)
• MTV's "Diary of Facebook" Features ALS Patients (March 31, 2011)
• Four Non-Profits Covering the Spectrum of Neurodegenerative Disease Collaborate on Key Disease Modeling Project (March 22, 2011)
• MDA's Augie's Quest Expands Testing of Potential ALS Therapeutics with New $2 Million Grant to ALS TDI (March 1, 2011)
• "National Cornhole Challenge Day" Organized by Young Faces of ALS Campaign (February 8, 2011)
• ALS TDI Appoints Anil Godhwani to Board of Directors (February 4, 2011)
• Young ALS Patients Come Together to End ALS with New National Campaign (May 21, 2010)
• Nature Genetics Article Shows a Link Between Gene Expression Profiling and Identification of Potential Treatment for ALS (March 28, 2010)
• Aestus Therapeutics, Inc. and ALS TDI Collaborate to Investigate Potential Treatments for ALS (March 16, 2010)
• California Stem Cell and ALS TDI Extend Collaboration (February 2, 2010)
• ALS Therapy Development Institute Receives $1.6 million Grant from the Department of Defense for Lou Gehrig's disease Research (January 12, 2010)
• Muscular Dystrophy Association Renews Partnership with ALS Therapy Development Institute to Develop New Treatments for Lou Gehrig's Disease (January 6, 2010)
• ALS Therapy Development Institute Partners with Applied Proteomics, Inc. to Develop Protein Based Biomarkers for Amyotrophic Lateral Sclerosis (December 14, 2009)
• Bay Area Youth to Represent ALS Patients at Giants' and Angels' Baseball Game on July 4th (July 3, 2009)
• Campaign to Increase the Awareness and Understanding of Lou Gehrig's Disease Reaches 22 U.S. States (May 18, 2009)
• ALS Therapy Development Institute; the world's largest non-profit biotech, appoints Steve Perrin, Ph.D. as Chief Executive Officer (May 1, 2009)
• ALS Therapy Development Institute Delivers Impassioned Testimony to Congressional Subcommittee on Veterans Affairs (April 28, 2009)
• ALS TDI and Major League Baseball Form "4ALS Awareness" Team to Combat Lou Gehrig's Disease (February 3, 2009)
• ALS TDI and Asklepios to Develop New Therapeutic Delivery Options for Treating Lou Gehrig's Disease (January 20, 2009)
• ALS Therapy Development Institute Awarded $1 Million Grant (October 28, 2008)
• ALS Patients and Researchers Unite for 4th Annual Leadership Summit (September 24, 2008)
• ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrig's Disease (August 19, 2008)
• ALS Therapy Development Institute and California Stem Cell, Inc. Announce Long-Term Scientific Collaboration (July 28, 2008)
• ALS Therapy Development Institute Signs Collaboration Agreement with the Allen Institute for Brain Science (April 08, 2008)
• Scientists Discover Why Animal Studies May Lead to Ineffective ALS Drugs (January 22, 2008)
• ALS Therapy Development Institute Signs Aptabody™ Discovery Agreement with Aptagen (January 7, 2008)
• ALS Researchers to Share Ideas with Each Other and Patients During Event at Museum of Science (October 16, 2007)
• ALS Therapy Development Institute Signs Manufacturing Agreement with Microbix Biosystems Inc. High Quality Adenoviral Production (October 16, 2007)
• ALS TDI Completes Gene Expression Profile of Lou Gehrig's Disease in Mice (October 2, 2007)